Company: EDSA
Filing Date: 2025-12-12
Form Type: 10-K
Source: 0001171843-25-007914
Chunk: 753

Company: Edesa Biotech, Inc.
Filing Date: 2025-12-12
Form: 10-K
Item: Item 4
Chunk 753
---
	36,047

			(8)

			* 

			Michael Brooks, PhD

			163,370

			(9)

			1.9

			%

			Peter Weiler

			14,448

			(10)

			* 

			Stephen Lemieux

			30,492

			(11)

			*

			All current directors and executive officers as a group (9 persons) 

			2,263,571

			(12)

			23.6

			%

* Percentage of shares beneficially owned does not exceed one percent.

			(1)

			Unless otherwise indicated, the address of each beneficial owner is c/o Edesa Biotech, Inc., 100 Spy Court, Markham, ON Canada L3R 5H6.

			(2)

			Consists of (i) 29 common shares, (ii) 2,858 common shares issuable upon exercise of options exercisable within sixty days of December 12, 2025 and (iii) 7,336 common shares issuable upon the conversion of restricted share units that have vested or will vest within sixty days of December 12, 2025.

			(3)

			Consists of (i) 2,053 common shares, (ii) 11,773 common shares issuable upon exercise of options exercisable within sixty days December 12, 2025 and (iii) 13,336 common shares issuable upon the conversion of restricted share units that have vested or will vest within sixty days of December 12, 2025.

			(4)
			
			Consists of (A) (i) 41,666 common shares, (ii) 2,858 common shares issuable upon exercise of options exercisable within sixty days December 12, 2025 and (iii) 7,336 common shares issuable upon the conversion of restricted share units that have vested or will vest within sixty days of December 12, 2025 held by Patrick Marshall and (B) 465 common shares held by Quidnet Inc. for which Patrick Marshall has sole voting and dispositive power over all such shares.

			(5)
			
			Consists of (A) (i) 84,973 common shares, (ii) 54,488 common shares issuable upon exercise of options exercisable within